Managing IP is part of the Delinian Group, Delinian Limited, 8 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2023

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

This week on MIP: EPO quality latest, Bayer interview

Lyon, France - October 20, 2016: Bayer office building. Bayer is

We provide a rundown of Managing IP’s news and analysis coverage from the week, and review what’s been happening elsewhere in IP

Excl: Counsel hopeful of EPO quality deal despite latest stalemate

The latest meeting between the EPO and industry critics ended without agreement but the atmosphere was much friendlier than in previous encounters, insider sources told Managing IP.

Members of the Industry Patent Quality Charter met with Steve Rowan, the EPO’s vice president of patent-granting processes, on Monday, May 8.

Click here to read the full story.

Bayer’s China IP head toasts record patent win amid pharma troubles

China isn’t the easiest jurisdiction to navigate for foreign intellectual property owners.

But Alex Liu, Bayer’s chief IP counsel in China, has picked up a trick or two having worked as a patent attorney in the country for more than 20 years.

Click here to read the full story.

Clarity needed after latest VICO decision: counsel

Another fight surrounding the position on videoconferencing at the EPO Boards of Appeal seems inevitable after the latest ruling on the issue, according to practitioners.

A BoA decision, published on Tuesday, May 9 but originally issued on April 25, found that in-person hearings were still the “gold standard” and parties could only be forced to use VICO in “very limited” conditions.

Click here to read the full story.

Other articles published by Managing IP this week include:

Weekly take: US Copyright Office’s latest AI ruling misses the mark

True colours: how bracelets will help fundraise at INTA

Up in smoke: US cannabis TM rejection shows need for caution

Collision course: how to navigate IP and marketing clashes

Sheeran win won't kill similar copyright claims: counsel

Elsewhere in IP

Gilead’s $1bn escape

Gilead’s HIV antivirals Truvada and Descovy did not infringe US government-owned patents, a Delaware federal jury found on Tuesday, May 9. The government sued Gilead over its failure to compensate government scientists for their patents related to HIV prevention. The government had sought up to $1 billion in damages.

Judge’s warning

A deputy judge at the England and Wales High Court warnedparties to be upfront about how long patent cases are likely to take on Wednesday, May 10. Campbell Forsyth made the remarks in a judgment dealing with two procedural applications in a patent dispute between Safestand and Weston Homes.

The two applications were originally estimated to take two and a half hours, but the hearing lasted a full day.

“It is important for parties to liaise and update the court if, as matters develop, the time the court requires to read into and hear a matter is considerably longer than originally anticipated and listed,” Forsyth wrote.

Enforcement head

President Joe Biden nominated intellectual property lawyer Deborah Robinson as IP Enforcement Coordinator on Monday, May 8. Robinson is head of IP enforcement at Paramount Global.

The International IP Alliance, a coalition of trade associations representing the creative industries, welcomed the nomination. “Given her vast experience and expertise on both domestic and foreign IP issues and in global enforcement, she is uniquely qualified to lead the important work of coordinating the US government’s effort to combat copyright infringement around the world,” a group statement said.

Bonfire out

The UK government has ditched its plan to let thousands of EU laws, including swathes of intellectual property law, expire at the end of this year. The move was confirmed by Kemi Badenoch, secretary of state for business and trade, on Wednesday, May 10.

The government’s original plan would have automatically removed EU-derived laws from the statute book unless they were replaced or specifically earmarked for retention. Instead, the government will focus on 600 EU-derived laws it wants to replace by the end of the year.

UPC nears

Government officials and judges from the Netherlands gathered in The Hague to open the city’s local division of the Unified Patent Court on Wednesday, May 10. Rian Kalden, who will serve as the UPC’s second most senior judge, was among those in attendance.

The UPC officially opens on June 1.

Reveal your secrets

Tangibly, a trade secret management platform, announced an early access programme for its new Patent X-Ray tool on Monday, May 8. The artificial intelligence-powered tool is designed to help teams identify undocumented trade secrets from their patents.

Users can put a US patent number into the tool, which then suggests trade secrets.

Attorneys at DLA Piper in the US and Italy have been piloting the technology.

That's it for today, see you again next week.

more from across site and ros bottom lb

More from across our site

IP counsel urge the government to restrict safe harbour exceptions available to intermediaries and clear up doubts with the existing law
A New York lawyer could face sanctions after citing fake judgments generated by ChatGPT, but that doesn’t mean practitioners should shy away from AI
Klaus Grabinski told delegates at a UPC inauguration event that the proposed SEP regulation would limit access to justice
We provide a rundown of Managing IP’s news and analysis coverage from the week, and review what’s been happening elsewhere in IP
Sukanya Sarkar shares her thoughts on this year’s annual meeting in Singapore, where debates ranged from AI opportunities to improving law firm culture
The court’s ruling is a good reminder that US parties aren’t guaranteed attorney fees just because they win, say sources
With business confidence in a shaky state, Rachel Tan and Lisa Yong of Rouse discuss how in-house IP teams can manage their trademark portfolios through uncertain times
The Court of Appeal had stern words for Med-El’s representatives after they highlighted a deputy judge’s background as a solicitor
Funders and NPEs say asserting patent portfolios can minimise risk at the USPTO’s PTAB, where procedure remains a controversial topic
The US Supreme Court’s ruling wasn’t a surprise and reflects a trend that had already been bubbling away for a while, say tech and pharma counsel